Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Emory University
The Hospital for Sick Children
Roswell Park Cancer Institute
University of Southern California
Massachusetts General Hospital
National Cancer Institute (NCI)
The University of Texas Health Science Center, Houston